Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms
Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms have?
Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms has 157 citations in the OpenAlex counts ScholarIQ stores.
When was Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms published?
Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms has 2021 year in the ScholarIQ index.
What is the open-access status of Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms?
Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms has hybrid oa status in the ScholarIQ index.
What is the DOI of Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms?
The DOI for Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms is on the source record.
What is the PMID of Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms?
The PMID for Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms is on the source record.
What is the OpenAlex record for Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms?
The OpenAlex for Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms is on the source record.